Page results
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
CAMLIS is the Royal London Hospital for Integrated Medicine (RLHIM) Complementary and Alternative Medicine Information and Library Service and is situated on the ground floor of the hospital.
-
This page has been written by the team in the mitochondrial clinic for patients who are seen at the National Hospital for Neurology and Neurosurgery, who have a diagnosis of mitochondrial disease.
-
Christmas is an exciting time even if it will be a bit different for us all this year. We might be spending more time inside, making us less active than usual for this time of year. However, it is still a good time to relax and enjoy some Christmas treats.
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
UCLH is continuing to scale up the number of services that offer Advice & Guidance, as well as identifying various improvements within the existing Advice & Guidance service. Over the last few months, UCLH has introduced 5 new specialties to the service, with additional specialties due to go live shortly.
-
UCLH is celebrating the delivery of its 1,000th respiratory syncytial virus (RSV) vaccine to pregnant women, following the rollout of the new national programme in September.
File results
-
FOI/2022/0315 - Role of patient safety specialists within the Trust
-
FOI/2022/0317 - Inpatient mental health facilities
-
FOI/2022/0318 - HIMMS Electronic Medical Record Adoption Model (EMRAM) level achieved at Trust
-
FOI/2022/0325 - Number of patients on the public RTT pathway
-
FOI/2022/0327 - Data Protection Officer job description
-
FOI/2022/0328 - Treatment for migraine
-
FOI/2022/0330 - Sleep and respiratory services
-
FOI/2022/0333 - Maternity care report
-
FOI/2022/0338 - X-ray reporting and interpretation of nasogastric tube placement
-
FOI/2022/0344 - Patient Administration System (PAS) used at Trust